Skystar Bio-Pharmaceutical Reports Fourth Quarter and Fiscal Year 2009 Financial Results (Marketwire)

Fourth Quarter Revenue of $10.9 Million Reflects 31% Growth YoY; Fiscal Year Revenue of $33.8 Million Reflects 32% Growth YoY; 2 Potential Acquisition Targets Identified